BioSpace News Archive

Bristol-Myers Squibb Company will take part in a fireside chat at the UBS Global Healthcare Conference on Tuesday, May 21, 2019, in New York.

ArQule, Inc. announced that Paolo Pucci, Chief Executive Officer, and Dr. Brian Schwartz, Chief Medical Officer and Head of Research and Development, will present at the 2019 RBC Capital Markets Global Healthcare Conference on May 21, 2019 at 3:35 p.m. ET at the InterContinental New York Barclay in New York City.

Third Phase of Collaborative Research Program Aims for a Cure

Al-driven applications enable a new era of intelligent engagement

Veeva Andi embeds insights and suggestions within Veeva CRM and makes it easy for life sciences to adopt and scale AI

ReForm Biologics announced a new customer. ReForm will perform feasibility studies for Bayer AG utilizing its innovative biotherapeutic technologies.

Company continues to show significant progress on developing highly selective antibodies targeting root cause of Alzheimer’s and Parkinson’s diseases and ALS

Haemonetics Corporation and CSL Plasma Inc. announced an agreement to transfer ownership of Haemonetics’ Union, South Carolina, manufacturing facility, operating assets and certain inventories to CSL Plasma.

New survey shows more can be done to protect those with a chronic condition

Company’s technology will transform care for patients with brain disorders and injuries